A T-CELL HYBRIDOMA MAY BE DRIVEN TO CELL-DEATH BY DIFFERENT PATHWAYS - COMPARATIVE EFFECT OF 2 STIMULI - HGCL2 AND ANTI-CD3 MONOCLONAL-ANTIBODY

被引：0
|
作者：
PONCET, P
BLANPIED, C
PRIGENT, P
YANG, Y
ASHWELL, JD
FEVRIER, M
ATEN, J
DRUET, P
HIRSCH, F
机构：
[1] HOP BROUSSAIS,INSERM,U28,F-75674 PARIS 14,FRANCE
[2] INST PASTEUR,F-75724 PARIS 15,FRANCE
[3] NCI,BETHESDA,MD 20892
来源：
JOURNAL OF IMMUNOLOGY | 1993年 / 150卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A193 / A193
页数：1
相关论文
共 50 条
  • [31] ANTI-CD2 AND ANTI-CD3 INDUCED T-CELL CYTOTOXICITY OF HUMAN INTRAEPITHELIAL AND LAMINA PROPRIA LYMPHOCYTES
    RUTHLEIN, J
    HEINZE, G
    AUER, IO
    GUT, 1992, 33 (12) : 1626 - 1632
  • [32] T-cell activation induced by anti-CD3 x anti-B-cell lymphoma monoclonal antibody is enhanced by pretreatment of lymphoma cells with soluble CD40 ligand
    Wooldridge, JE
    Dahle, CE
    Weiner, GJ
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 45 (3-4) : 174 - 179
  • [33] MERCURIC CHLORIDE-INDUCED PROGRAMMED CELL-DEATH OF A MURINE T-CELL HYBRIDOMA .2. OPPOSITE EFFECT OF INTERLEUKIN-2 AND INTERLEUKIN-4
    PRIGENT, P
    PONCET, P
    ATEN, J
    BLANPIED, C
    CHAND, A
    FEVRIER, M
    DRUET, P
    HIRSCH, F
    CELLULAR IMMUNOLOGY, 1995, 161 (01) : 107 - 111
  • [34] SPECIFIC-INHIBITION OF OKT3-DRIVEN T-CELL MITOGENESIS BY AN ANTI HLA-CLASS-I MONOCLONAL-ANTIBODY
    BECKMAN, I
    XIAONING, X
    BRADLEY, J
    IMMUNOLOGY, 1988, 65 (03) : 373 - 378
  • [35] ACTIVATION OF CORD LYMPHOCYTES-T .2. CELLULAR AND MOLECULAR ANALYSIS OF THE DEFECTIVE RESPONSE INDUCED BY ANTI-CD3 MONOCLONAL-ANTIBODY
    BERTOTTO, A
    GERLI, R
    LANFRANCONE, L
    CRUPI, S
    ARCANGELI, C
    CERNETTI, C
    SPINOZZI, F
    RAMBOTTI, P
    CELLULAR IMMUNOLOGY, 1990, 127 (02) : 247 - 259
  • [36] COOPERATION BETWEEN AN ANTI-T-CELL (ANTI-CD28) MONOCLONAL-ANTIBODY AND MONOCYTE-PRODUCED IL-6 IN THE INDUCTION OF T-CELL RESPONSIVENESS TO IL-2
    BAROJA, ML
    CEUPPENS, JL
    VANDAMME, J
    BILLIAU, A
    JOURNAL OF IMMUNOLOGY, 1988, 141 (05): : 1502 - 1507
  • [37] Combining anti-CD3 activated T cells armed with anti-CD3 x anti-Her2 bispecific antibody may provide an additional anti-tumor effect after stem cell transplant for breast cancer.
    Sen, M
    Wankowski, DM
    Lum, LG
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 743 - 743
  • [38] T-CELL ACTIVATION THROUGH TCR/-CD3 COMPLEX - IL-2 PRODUCTION OF T-CELL CLONES STIMULATED WITH ANTI-CD3 WITHOUT CROSS-LINKAGE
    TAMURA, T
    NARIUCHI, H
    JOURNAL OF IMMUNOLOGY, 1992, 148 (08): : 2370 - 2377
  • [39] IN-VIVO T-CELL ACTIVATION BY ANTI-CD3 MONOCLONAL-ANTIBODY INDUCES SOLUBLE TNF RECEPTOR RELEASE IN MICE - EFFECTS OF PENTOXIFYLLINE, METHYLPREDNISOLONE, ANTI-TNF, AND ANTI-IFN-GAMMA ANTIBODIES
    BEMELMANS, MHA
    ABRAMOWICZ, D
    GOUMA, DJ
    GOLDMAN, M
    BUURMAN, WA
    JOURNAL OF IMMUNOLOGY, 1994, 153 (02): : 499 - 506
  • [40] GENERATION OF CD4+ CYTOTOXIC T-LYMPHOCYTES STIMULATED BY IMMOBILIZED ANTI-CD3 MONOCLONAL-ANTIBODY AND INTERLEUKIN-2 IN CANCER-PATIENTS
    TANI, M
    TANIMURA, H
    YAMAUE, H
    MIZOBATA, S
    IWAHASHI, M
    TSUNODA, T
    NOGUCHI, K
    TAMAI, M
    HOTTA, T
    TERASAWA, H
    ARII, K
    INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (06) : 802 - 807
12345